A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Study Summary

A study of CT-RD06 cell injection in patients with relapsed or refractory CD19+ B-cell hematological malignancy.

Interventions

Study Locations

Facility	City	State	Country
The First Hospital of Zhejiang Medical Colleage Zhejiang University	Hangzhou	Zhejiang	China

Official Trial Information

View on ClinicalTrials.gov